Literature DB >> 6547671

Expression of aldolase isozyme mRNAs in fetal rat liver.

M Numazaki, K Tsutsumi, R Tsutsumi, K Ishikawa.   

Abstract

The regulation of aldolase isozyme expression during development was studied by measuring the concentrations of mRNAs coding for aldolase A and B subunits in fetal and adult rat liver. Poly(A)-containing RNAs were extracted from livers at various stages of development of fetal rats, and the aldolase A and B subunits in the in vitro translation products of these RNAs were analyzed immunologically. The content of aldolase B mRNA in 14-day fetal liver, measured quantitatively as translational activity, was somewhat smaller than that of aldolase A mRNA; immunologically precipitable aldolase B and A amounted to 0.06% and 0.25% respectively, of the total products. Similar experiments using RNAs from fetuses at later stages, however, showed that aldolase B mRNA increased during development, whereas aldolase A mRNA decreased. In newborn rat liver, aldolase B constituted 0.56% of the total translation products of mRNA, but there was little detectable aldolase A (0.03%). The changes of aldolase mRNA levels were analyzed further by northern blot and dot-blot hybridization experiments using cloned aldolase A and B cDNAs. The content of aldolase B mRNA increased in the fetal stage, and that in newborn rat liver was about 12 times that in 14-day fetal liver. In contrast, the aldolase A mRNA content decreased during gestation and that in newborn rat liver was about one-eighth of that in 14-day fetal liver. These observations suggest that the switch of aldolase isozyme expression in fetal liver is controlled by the levels of the respective mRNAs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547671     DOI: 10.1111/j.1432-1033.1984.tb08265.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Changes of aldolase isozyme gene expression in CCl4 induced liver damage.

Authors:  M Motomura; I Ozaki; Y Setoguchi; K Yamamoto; T Sakai; K Hori
Journal:  Gastroenterol Jpn       Date:  1990-08

2.  Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter.

Authors:  M Raymondjean; A L Pichard; C Gregori; F Ginot; A Kahn
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

3.  Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.

Authors:  Celine V M Cluzeau; Dawn E Watkins-Chow; Rao Fu; Bhavesh Borate; Nicole Yanjanin; Michelle K Dail; Cristin D Davidson; Steven U Walkley; Daniel S Ory; Christopher A Wassif; William J Pavan; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2012-05-22       Impact factor: 6.150

4.  Transcriptional control of the rat hepatic CYP2E1 gene.

Authors:  T Ueno; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

5.  Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene.

Authors:  K Tsutsumi; K Ito; K Ishikawa
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Transcriptional regulation of an aldolase gene in the regenerating rat liver.

Authors:  M Motomura; T Mukai; I Ozaki; K Joh; Y Arai; T Sakai; K Hori
Journal:  Gastroenterol Jpn       Date:  1990-06

Review 7.  Hereditary fructose intolerance.

Authors:  M Ali; P Rellos; T M Cox
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

8.  Regulation of glycolytic enzyme RNA transcriptional rates by oxygen availability in skeletal muscle cells.

Authors:  K A Webster
Journal:  Mol Cell Biochem       Date:  1987-09       Impact factor: 3.396

9.  RNA interference-induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice.

Authors:  Paul N Valdmanis; Shuo Gu; Kirk Chu; Lan Jin; Feijie Zhang; Elizabeth M Munding; Yue Zhang; Yong Huang; Huban Kutay; Kalpana Ghoshal; Leszek Lisowski; Mark A Kay
Journal:  Nat Med       Date:  2016-04-11       Impact factor: 53.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.